Intravenous Immunoglobulin in Patients With Anti-GAD Antibody-Associated Neurological Diseases and Patients With Inflammatory Myopathies: Effects on Clinicopathological Features and Immunoregulatory Genes

Author： Dalakas Marinos C.  

Publisher： Humana Press, Inc

ISSN： 1080-0549

Source： Clinical Reviews in Allergy and Immunology, Vol.29, Iss.3, 2005-12, pp. : 255-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Downregulation of TGF-β1 mRNA and Protein in the Muscles of Patients with Inflammatory Myopathies after Treatment with High-Dose Intravenous Immunoglobulin

By Amemiya K.   Semino-Mora C.   Granger R.P.   Dalakas M.C.  

Clinical Immunology, Vol. 94, Iss. 2, 2000-02 ,pp. : 99-104

Academic Press

Access to resources Recommend Favorite

The response to intravenous immunoglobulin replacement therapy in patients with asthma with specific antibody deficiency

By Schwartz Howard J.   Hostoffer Robert W.   McFadden E. Regis   Berger Melvin  

Allergy and Asthma Proceedings, Vol. 27, Iss. 1, 2006-01 ,pp. : 53-58

OceanSide Publications, Inc

Access to resources Recommend Favorite

Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases

By Krasovec S.   Ornani A.   Oleastro M.   Rosenzweig S.   Roy A.   Perez L.   Campos G.   MarÍn N.   Martinez A.   Mahieu C.   Manfredi M.   Sisti A.   Zelazko M.  

Journal of Clinical Immunology, Vol. 27, Iss. 2, 2007-03 ,pp. : 227-232

Springer Publishing Company

Access to resources Recommend Favorite

Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases

By Bayry J.   Misra N.   Latry V.   Prost F.   Delignat S.   Lacroix-Desmazes S.   Kazatchkine M.D.   Kaveri S.V.  

Transfusion Clinique et Biologique, Vol. 10, Iss. 3, 2003-05 ,pp. : 165-169

Elsevier

Access to resources Recommend Favorite

Safety and Tolerability of Increased Rate of Infusion of Intravenous Immunoglobulin G, 10% in Antibody-Deficient Patients

By Gelfand Erwin   Hanna Kim  

Journal of Clinical Immunology, Vol. 26, Iss. 3, 2006-05 ,pp. : 284-290

Springer Publishing Company

Access to resources Recommend Favorite